mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.006 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.007 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |